CXCL2 and neoplasm: CCL2, CXCL1 and CXCL2 expressed by IECs, stromal and tumor cells during CRC possess pro-tumoral capacities since they chemoattract myeloid cells including neutrophils and tumor-associated macrophages, and stimulate angiogenesis [31, 32].